Glucotrack’s Subsidiary Lōkahi Therapeutics Unveils Qare Comparative Health Platform For GLP-1 And Other Treatment Outcomes
Glucotrack Subsidiary Lōkahi Therapeutics Engaged Two ai² PIPELINE Project Teams To Identify And Evaluate Brain Tumor Therapeutic Assets Available For Licensing And Development
Glucotrack’s Lōkahi Therapeutics Announces University Of Alabama’s Culverhouse College Of Business Will Continue Its Participation In ai² Pipeline Division For Upcoming Academic Year